CSL Behring plans €185M expansion in Marburg, Germany

CSL Behring announced a €185 million expansion of its facility in Marburg, Germany, to increase production capacity for hereditary angioedema treatments, expected to be completed in 2023, creating 50 jobs.

“CSL Behring has announced plans for a 185 million euro ($203 million) expansion in Marburg, Germany, where the global biotech already has its largest research and production facility.”csl.com

• 1 source
• csl.comCSL Behring Expands in Germany to Meet DemandDebra Moffitt, Laura KumpeSep 12, 2019

Summarized from public sources; check the original articles before acting on it.